Listen Download Podcast
  • RFI English News flash 04h00 - 04h10 GMT Mon-Fri
    News bulletin 09/28 04h00 GMT
  • Paris Live AM 04h10 - 04h30 GMT Mon-Fri
    Features and analysis 09/28 04h10 GMT
  • RFI English News flash 05h00 - 05h10 GMT Mon-Fri
    News bulletin 09/28 05h00 GMT
  • Paris Live AM 05h10 - 05h30 GMT Mon-Fri
    Features and analysis 09/28 05h10 GMT
  • RFI English News flash 06h00 - 06h10 GMT Mon-Fri
    News bulletin 09/28 06h00 GMT
  • Paris Live AM 06h10 - 06h30 GMT Mon-Fri
    Features and analysis 09/28 06h10 GMT
  • RFI English News flash 06h30 - 06h33 GMT Mon-Fri
    News bulletin 09/28 06h30 GMT
  • Paris Live AM 06h33 - 06h59 GMT Mon-Fri
    Features and analysis 09/28 06h33 GMT
  • RFI English News flash 07h00 - 07h10 GMT Mon-Fri
    News bulletin 09/28 07h00 GMT
  • RFI English News flash 07h30 - 07h33 GMT Mon-Fri
    News bulletin 09/28 07h30 GMT
  • RFI English News flash 14h00 - 14h03 GMT Sat-Sun
    News bulletin 09/25 14h00 GMT
  • RFI English News flash 14h00 - 14h06 GMT Mon-Fri
    News bulletin 09/28 14h00 GMT
  • Paris Live Weekend 14h03 - 14h30 GMT Sat-Sun
    Features and analysis 09/25 14h03 GMT
  • Paris Live PM 14h06 - 14h30 GMT Mon-Fri
    Features and analysis 09/28 14h06 GMT
  • RFI English News flash 14h30 - 14h33 GMT Mon-Fri
    News bulletin 09/28 14h30 GMT
  • Paris Live PM 14h33 - 14h59 GMT Mon-Fri
    Features and analysis 09/28 14h33 GMT
  • RFI English News flash 16h00 - 16h03 GMT Sat-Sun
    News bulletin 09/25 16h00 GMT
  • RFI English News flash 16h00 - 16h06 GMT Sat-Sun
    News bulletin 09/28 16h00 GMT
  • Paris Live Weekend 16h03 - 16h30 GMT Sat-Sun
    Features and analysis 09/25 16h03 GMT
  • RFI English News flash 16h30 - 16h33 GMT Mon-Fri
    News bulletin 09/28 16h30 GMT
  • Paris Live Weekend 16h33 - 17h00 GMT Sat-Sun
    Features and analysis 09/25 16h33 GMT
To take full advantage of multimedia content, you must have the Flash plugin installed in your browser. To connect, you need to enable cookies in your browser settings. For an optimal navigation, the RFI site is compatible with the following browsers: Internet Explorer 8 and above, Firefox 10 and +, Safari 3+, Chrome 17 and + etc.
Economy

PIP breast implant trial begins in Marseille

media PIP founder Jean-Claude Mas Reuters/Philippe Laurenson

The trial of five executives of the PIP breat-implant company started in Marseille at 9.30 am on Wednesday morning in one of the biggest court proceedings in France’s history. Over 5,200 women have declared themselves plaintiffs and 300 were present on the first day.

The defendants are accused of aggravated fraud for using cheap industrial-grade and agricultural-grade silicone in breast implants for 10 years and concealing evidence from inspectors.

The defendants are:

  • PIP founder Jean-Clade Mas;
  • Chair of the board of directors Claude Couty;
  • Director of production manager Loïc Gossart;
  • Technical director Thierry Brinon;
  • Quality director Hannelore Font.
     

They face up to five years in jail and a 37,500-euro fine if convicted.

As the trial began, Mas, who was jailed for several months for failing to pay 100,000 euros bail, was booed when he took the stand to state his name and profession.

He had earlier arrived, accompanied by his lawyer, Yves Haddad, who complained of media treatement of his client, who will turn 74 next month.

"Whatever happened, what you are doing to a 74-year-old man is not dignified," he told reporters.

PIP was the world’s third largest supplier of breast implants and sold 300,000 in 65 countries.

About 4,000 French women report ruptures in their implants and about half of the 30,000 who had them have had them removed.

Most of the plaintiffs are French but 220 are from abroad.

Other trials are expected to take place involving different plaintiffs.

To accommodate the plaintiffs and their 300 lawyers, the trial is being held in a conference centre in the southern French city at the cost of 800,000 euros.

Some lawyers for the plaintiffs are also expected to request the case be expanded to include others they claim should be held responsible, such as plastic surgeons, public health authorities and a German safety standards firm that gave the implants the go-ahead.

Health officials in several countries have said the implants are not toxic and do not increase the risk of breast cancer.

A 10-year case study has been launched in France to determine the long-term effects.

Related
 
Sorry but the period of time connection to the operation is exceeded.